“It is a consistent strategy of BTS to serve the customers on-site, and through the establishment of the India Office we now provide tailored services to Indian customers in the chemical and pharmaceutical industries,” said Noack at the ceremony. The services include all phases of investment projects, state-of-the-art technological solutions and optimization tools to improve energy efficiency or supply chains, to name only a few.

Since its legal independence in October 2003 the company continues to support BayerZs operating subgroups in the design, construction and optimization of plants and also markets these services to external customers worldwide.

Operating as a subsidiary of Bayer Technology Services GmbH, Bayer Technology and Engineering (Shanghai) Company Ltd. and its affiliates in Shanghai and now India have been established to serve the international engineering service company’s growing number of customers in the Asia Pacific region. Dr. Knors stressed that the company’s competence in Asia lies in its excellent knowledge of the local market coupled with global expertise and its professional team. “We see great potential in this market. We are also fully capable to stand locally as a trustee to our customers in evaluating and supplying high quality technical equipment made in Asia to the customers worldwide,” said Dr. Knors.

About Bayer Technology Services
Bayer Technology Services GmbH offers fully-integrated solutions along the life cycle of chemical/pharmaceutical plants – from development through engineering and construction to process optimization for existing plants. The Bayer subsidiary employs nearly 2,600 experts worldwide at its headquarters in Leverkusen and other German locations, as well as in regional offices in USA, Mexico, Belgium, Switzerland, United Arab Emirates, India and Peoples Republic of China.
In 2008 sales totaled approximately EUR 420 million.

Additional information about Bayer Technology Services: www.bayertechnology.com.


Forward-Looking Statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those described by Bayer in published reports. These reports are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.